A股異動丨新泉股份(603179.SH)漲近6%創新高 績後獲券商唱好
格隆匯8月7日丨新泉股份(603179.SH)逆勢漲5.68%,報27.7元,暫成交1.67億元,最新總市值85.7億元。公司股價自8月3日以來累計漲幅近30%創新高。新泉股份8月4日公佈,上半年淨利同比增6.2%至9868.39萬元,Q2單季度營收同比增長30%,歸母淨利潤同比增長71%。報告期內與特斯拉等達成合作。天風證券稱,公司20Q2業績超預期,成功配套特斯拉,維持“買入”評級。太平洋證券表示,公司業績如期高增,成長開始兑現。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.